Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [8]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Program
        • PEP++ project
        • PEP4LEP 2.0 & PEP4LEP
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
    • PEP4LEP 2.0 & PEP4LEP
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [16]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
      • Health-related Perception Inquiry
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • Prevention of Leprosy (SDR-PEP) Toolkit
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Dapsone-induced agranulocytosis presenting as neutropenic sepsis in borderline tuberculoid leprosy

Wickramanayake A, Rajadurai AS, Adhikari K, et al. Sri Lanka Journals Online. Sri Lanka Journal of Dermatology. 2026; 25 (1) : 134-137.
Download PDF
Publication

Determinants of Compliance with Lawrence Green Theory-Based Leprosy Treatment in Leprosy Patients in Sarmi Regency, Papua Province

Indasah , Meilani Erna Horota . STRADA : Jurnal Ilmiah Kesehatan. 2026; 15 (1) : 11 - 17.
Download PDF
Publication

Therapeutic vaccines and adjunctive immunotherapeutic approaches to multidrug therapy for the management of leprosy: A multiaxial review of evidence and trajectory

Ashinze P, Adenekan T, Noze-Otote O, et al. VM Media Group sp. z o.o. Forum Dermatologicum. 2026;
Download PDF
Publication

Mathematical modeling of type II lepra reactions: Cytokine dynamics and the impact of multi drug therapy (MDT) and thalidomide

Ramanjaneyulu C, Vamsi D. Elsevier BV. Next Research. 2026;
Download PDF
Publication

Lepromatous Leprosy Presenting With Preserved Sensation: A Case Report

Shiyanbola AC, Emezie PC, Saheed O, et al. Springer Science and Business Media LLC. Cureus. 2026; 18 (5) : 1 - 12.
Download PDF
Publication

Serum Neurofilament Light Chain Levels in Leprosy Patients: A Cross-Sectional Study

Khurana A, Sharath S, Subramanian S, et al. Tropical medicine & international health : TM & IH. 2026;
Publication

The Use of a Multi-Drug Therapy (MDT) Monitoring Calendar as a Medium to Support Medication Adherence in Leprosy Patients

Marianti Agustina Gudipun , Yoany Maria Vianney Bita Aty , Maria Selestina Sekunda , et al. Lembaga Penelitian dan Pengabdian Kepada Masyarakat Universitas Harapan Bangsa. Viva Medika: Jurnal Kesehatan, Kebidanan dan Keperawatan. 2026; 19 (1) : 9-18.
Download PDF
Publication

Type 2 Lepra Reaction Presenting as Pyrexia of Unknown Origin: A Case Report

Rajbarath , Purn Pragya , S. S. Singh , et al. International Journal of Medical and Pharmaceutical Research. 2026; 7 (1) : 2584-2585.
Download PDF
Publication

The Multifaceted Manifestations of Type 2 Lepra reaction: A Series of Four Cases

Manickam, N, Pooja Senthil , Dhivya Palaniyappan , et al. Advanced Research Publications. Journal of Communicable Diseases. 2025; 56 (02) : 142-149.
Download PDF
Publication

Unveiling Lepromatous Leprosy in a Non-endemic Region: A Case of Delayed Diagnosis and Effective ROM (Rifampin, Ofloxacin, and Minocycline) Therapy

McCarter M, Hassevoort K, Lane J, et al. Springer Science and Business Media LLC. Cureus. 2026;
Download PDF

Pagination

  • Page 1
  • Next page ››
Subscribe to Multi-drug therapy (MDT)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2026 InfoNTD